🚀 Avro: Needle-free Vaccines

Image being vaccinated without the injection | Drop #46

This drop, we’re proud to shout out our friends at Console!

✨Console - Beef Up Your Engineering Knowledge✨

Join thousands of engineers in learning about the latest in open-source software, curated by an Amazon engineer.

Console is a weekly round-up of open-source projects. If you subscribe today, you’ll get special access to an archive of all Console blog posts via email.

It’s free - just click below! 👇

Subscribe to Console today!


By now, a lot of us have gotten our covid jabs. But, imagine a world where that vaccine was delivered, not through a needle, but rather a lotion or ointment. This week's startup has a revolutionary take on vaccine administration.

The Elevator Pitch:

Avro Life Science Therapeutics is focused on turning injectable therapeutics (vaccines, needle-based treatments) into passive transdermal systems (ointments, lotions, scrubs, etc). They believe that topical delivery (surface-level on the skin only) is the future of therapy. The way they do this is by creating solutions of small molecules and peptides, combined with larger, more complex structures (proteins, antibodies, nucleic acids, etc) to deliver medicine without the need of needles.

They currently have 7 therapies that are either going through clinical trials or are in the early stages of development. The therapies they are aiming to support currently include diseases like Parkinson's and ALS, all the way to lesser-known conditions like atopic dermatitis and psoriasis. This approach to medicine delivery is quite novel and this company is a pioneer at the forefront of a futuristic medical paradigm.

👇 The Drop Down

Site : https://www.avrolifesci.com/
Founded: 2018
Stage: Pre-Seed
Trend: Biotechnology
Traction: 7+ Therapies in the pipeline, Supported by YC + Thiel Fellowship, Team of 12 Scientists, Researchers, and Chemists
Team -University of Waterloo PharmD and Nanotechnology Students, YC Alumni
Shak L. - Co-Founder & CEO (Thiel Fellow)
Keean S. - Co-Founder

🔍 Why we like it

  1. 💡 Forefront of a new paradigm
    Injections have been around since the 1850's. While the quality of injections has significantly increased (after humans studied mosquitos), the premise of having an injection has not been questioned — until now. It is pretty obvious that if someone had to pick between an injection and a lotion, they would go with the lotion. If Avro cracks the code to delivering therapies and medication with equivalent quality to that of injection, it would rattle the very baseline of many multi-billion dollar medical corporations.

  2. 📈 Right Time & Right Team
    Medical innovation has never been more relevant. Now that the world is recovering from the pandemic, awareness of the medical system has shot up: The world has become educated and understands the importance of medical advancements. YCombinator and Thiel Fellowship have already caught on and understand that Avro is onto something special, we think it's just a little time before everyone else realizes it too.

🤝 Get involved with Avro

  • Check out their website

  • Read up on some of the medical studies that back their claims: one, two, and three

  • Wanna join the team? Apply here


Subscribe to learn about more amazing startups!